Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25212790 | 0.98 | CYP1A2 (0.55) | CYP1A2MAPK1SMN1; SMN2CXCR4CHRM5 | |
| SCHEMBL9937405 | 0.91 | SMN1; SMN2 (0.62) | CYP1A2MAPK1SMN1; SMN2CXCR4CHRM5 | |
| SCHEMBL3777682 | 0.91 | SMN1; SMN2 (0.62) | CYP1A2MAPK1SMN1; SMN2CXCR4CHRM5 | |
| SCHEMBL3193772 | 0.90 | GLA (0.46) | CYP1A2MAPK1SMN1; SMN2CXCR4CHRM5 | |
| Glutarate SCHEMBL11904902 | 0.90 | SIGMAR1 (0.44) | CYP1A2MAPK1SMN1; SMN2CHRM5CHRM3 | |
| SCHEMBL1494479 | 0.89 | SMN1; SMN2 (0.64) | CYP1A2MAPK1SMN1; SMN2CXCR4CHRM5 | |
| Hydrochloric Acid SCHEMBL27554302 | 0.88 | SMN1; SMN2 (0.62) | CYP1A2MAPK1SMN1; SMN2CXCR4CHRM5 | |
| SCHEMBL8512409 | 0.88 | CYP1A2 (0.67) | CYP1A2MAPK1SMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL23854090 | 0.88 | CYP1A2 (0.67) | CYP1A2MAPK1SMN1; SMN2LMNAHSD17B10 | |
| SCHEMBL3970630 | 0.86 | HSD17B10 (0.50) | SMN1; SMN2CXCR4CHRM5CHRM3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210228750-A1 | POLYMERIC CORE-SHELL PARTICLES | BAR-ILAN UNIVERSITY (IL) | 2021-07-29 | — | — | US | claimed |
| EP-3787696-A1 | POLYMERIC CORE-SHELL PARTICLES | Bar-Ilan University (IL) | 2021-03-10 | — | — | EP | claimed |
| US-20210228750-A1 | POLYMERIC CORE-SHELL PARTICLES | BAR-ILAN UNIVERSITY (IL) | 2021-07-29 | — | — | US | disclosed |
| EP-3787696-A1 | POLYMERIC CORE-SHELL PARTICLES | Bar-Ilan University (IL) | 2021-03-10 | — | — | EP | disclosed |
| EP-1603598-B1 | RADIOLABELED CONJUGATES BASED ON SUBSTANCE P AND THE USES THEREOF | UNIVERSITAETSSPITAL BASEL (CH) | 2008-10-08 | — | — | EP | disclosed |
| US-20070053837-A1 | Radiopharmaceuticals for cancer diagnosis and treatment | KANTONSSPITAL BASEL (CH) | 2007-03-08 | — | — | US | disclosed |
| EP-1603598-A2 | RADIOLABELED CONJUGATES BASED ON SUBSTANCE P AND THE USES THEREOF | Universitätsspital Basel (CH) | 2005-12-14 | — | — | EP | disclosed |
| WO-2004082722-A2 | RADIOLABELED CONJUGATES BASED ON SUBSTANCE P AND THE USES THEREOF | UNIVERSITÄTSSPITAL BASEL (CH) | 2004-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070053837-A1 | Radiopharmaceuticals for cancer diagnosis and treatment | TACR1, GRPR, SSTR1 | CYP1A2 4202/4885MAPK1 3635/4885SMN1; SMN2 2940/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.